REG - MicroSalt PLC - New Strategic Relationship with Daiya Foods

MicroSaltAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251112:nRSL1352Ha&default-theme=true

RNS Number : 1352H  MicroSalt PLC  12 November 2025

 

 

 

 

 

 

12 November 2025

 

MicroSalt plc

("MicroSalt" or the "Company")

 

New Strategic Relationship with Daiya Foods

 

MicroSalt announces a new strategic relationship with Daiya Foods, a leader in
dairy-free and plant-based innovation foods.

 

MicroSalt plc (AIM: SALT), a leading manufacturer of full-flavour natural salt
with approximately 50% less sodium, is pleased to announce a new relationship
with Daiya Foods Inc. ("Daiya Foods"), a global leader in dairy-free and
plant-based food innovation. MicroSalt has received an initial order of $50k
to begin production and its projected 2026 volume to approximate $500k.

 

Acquired by Otsuka Pharmaceutical Co., Ltd in 2017 for $405 million, Daiya
Foods is recognised for pioneering dairy-free products that deliver the taste,
texture, and nutritional satisfaction consumers expect from traditional dairy
foods. Available in 25,000 grocery stores in the US and Canada, as well as
through e-commerce partnerships, Daiya Foods' products can be found
internationally in Asia, Europe, and Latin America.

 

MicroSalt expects to be integrated into the Daiya Foods portfolio of product
lines, with an initial focus on cheese and pizza dough, supporting Daiya
Foods' mission to provide delicious, accessible, and healthier plant-based
alternatives. The collaboration represents an important step in expanding
MicroSalt's reach beyond the snack sector into broader food applications where
sodium reduction has traditionally challenged flavour and functionality.

 

This collaboration further reinforces MicroSalt's position as a preferred
partner for global food manufacturers seeking to meet consumer demand for
healthier, full-flavour products. As the drive toward sodium reduction
accelerates across international markets, MicroSalt continues to expand its
footprint across multiple categories, from snacks and condiments to frozen
meals and dairy alternatives, enabling brands to achieve meaningful sodium
reduction without compromise on taste or texture.

 

Rick Guiney, CEO of MicroSalt, commented:

 

"We're very pleased to align efforts with Daiya Foods, a company that shares
our vision of making healthier eating both delicious and accessible. This
collaboration demonstrates the versatility of MicroSalt's technology across
diverse food categories-from dairy-free alternatives to frozen meals and
sauces. It's another step in our journey to make sodium reduction a standard
part of holistic, better-for-you reformulation across the food industry."

 

Enquiries:

 

 MicroSalt plc                                   c/o +44 (0)20 4582 3500
 Rick Guiney, CEO

 Zeus (Nominated adviser and broker)             +44 (0)20 3829 5000
 David Foreman, James Edis (Investment Banking)

 Gracechurch Group (Financial PR)                +44 (0)20 4582 3500
 Heather Armstrong, Alexis Gore, Rebecca Scott

 

About MicroSalt

 

MicroSalt is disrupting the global salt market with its patented,
full-flavour, low-sodium salt designed for both food manufacturers and
consumers. Using proprietary micron-sized particles, MicroSalt® delivers the
same salty taste as traditional salt with approximately 50% less sodium,
offering a scalable solution to one of the world's most pressing health
challenges. Year to date through 2025, MicroSalt® has contributed to more
than 634M servings made healthier.

 

Excess sodium consumption is a leading contributor to cardiovascular disease,
the world's number one cause of death. The World Health Organisation has
targeted a 30% reduction in global sodium intake by 2025, a shift projected to
save seven million lives by 2030. The economic case is equally compelling: in
the UK alone, cardiovascular disease costs £19 billion annually, and reducing
average daily salt intake by just one gram could save over 4,000 lives and
£288 million each year.

 

Operational since 2018, MicroSalt has established a defensible IP portfolio,
holding a granted US patent and 14 pending applications worldwide. These
protections create significant barriers to entry in a market expected to grow
exponentially as regulation and consumer demand accelerate.

 

MicroSalt is ideally positioned for scale and market leadership, with clear
pathways into food manufacturing, consumer channels, and ultimately the
broader £10+ billion global salt market. MicroSalt is more than a healthier
alternative-it is a disruptive, category-defining solution poised to deliver
significant commercial and societal impact.

 

For more information, please visit www.microsaltinc.co
(http://www.microsaltinc.co) or follow on X @microSaltPLC.

 

About Daiya Foods Inc.

 

Daiya Foods Inc. is a pioneering Canadian food company committed to creating
plant-based comfort foods for everyone. Founded in 2008 and headquartered in
Burnaby, British Columbia, Daiya has grown from its origins in dairy-free
cheese alternatives to a broad portfolio of dairy-free pizzas, mac &
cheese, desserts and more. The Company's products are allergen-friendly (free
of dairy, soy, gluten and nuts in many cases), non-GMO certified, and designed
to deliver the taste, texture and melt of conventional comfort foods - without
compromise.

 

Backed by global parent Otsuka Pharmaceutical Co., Ltd., Daiya is committed to
innovation, sustainability and inclusivity. From its LEED-certified production
facility in British Columbia to its mission of "cheese reimagined" for all,
Daiya is leading the charge in the plant-based movement.

 

To learn more, visit www.daiyafoods.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCBRBDBXXBDGUB



            Copyright 2019 Regulatory News Service, all rights reserved